Autophagy and Mitophagy: Pathway and Mechanisms Explained

Human cells are classified into three types based on division capacity: labile cells (continuously divide, e.g., skin, intestinal cells), stable cells (can divide in response to injury, e.g., liver, kidney cells), and permanent/terminal cells (never divide, e.g., heart muscle, neurons). Homeostasis is the maintenance of normal cellular structure and function where each cell type performs specific functions through specific structures. When cells face stress (physiological or pathological), they respond in a spectrum: first adaptations (reversible structural changes to achieve new homeostasis), then reversible injury, and finally irreversible cell death (apoptosis/necrosis). Cell adaptations are reversible responses to stress that achieve new homeostasis. The five types are: hypertrophy (cell size increase), hyperplasia (cell number increase), atrophy (cell size decrease), metaplasia (epithelial cell type conversion), and dysplasia (disordered development, neoplasia precursor). Hyperplasia occurs through increased growth factor production and receptor expression, shown by labile and stable cells but not permanent cells. Physiological examples include female breast enlargement during puberty/pregnancy/lactation, uterine myometrium expansion during pregnancy (combined hypertrophy/hyperplasia), and endometrial regeneration post-menstruation. Pathological examples include HPV-induced skin warts, estrogen-induced endometrial hyperplasia (causing abnormal bleeding), and compensatory hyperplasia after partial organ resection.

Cell stress is defined as a disruption of homeostasis within the cell, occurring when internal balance is disturbed. Similar to human stress from deadlines and responsibilities, cells experience stress from various factors including temperature extremes, insufficient oxygen, inadequate nutrients, and excessive protein demands. The cell responds by initiating mechanisms to restore balance, analogous to how the body regulates temperature through sweating when overheated. This fundamental principle applies across all organizational levels from entire organisms down to individual organelles.

Cells maintain homeostasis through balanced metabolic needs, waste elimination, and workload. When disrupted by harmful stimuli, cells may adapt, suffer reversible damage, or undergo irreversible damage leading to death. The determining factor is stimulus intensity and persistence. Cells have preprogrammed responses including integrated stress response, ER stress response, and autophagy. Using cardiac muscle as an example, hypertrophy initially compensates for increased workload but can become pathological by reducing ventricular cavity size and decreasing cardiac output. The hypertrophic muscle is more susceptible to ischemic damage due to higher oxygen demands and compressed coronary arteries. Cellular damage results from diverse causes: physical agents (temperature extremes, radiation, pressure changes), chemical agents (toxins, medications, heavy metals), infectious agents, immune-mediated damage, genetic abnormalities, and nutritional deficiencies.

Homeostasis is the body's ability to maintain stable internal conditions despite external changes. Cells strive to maintain their normal state and adjust to environmental changes. When cells experience stress (such as being cut), they attempt to adapt. If adaptation succeeds, the cell returns to normal. If the stress is too severe, the cell becomes injured. Cell injury can be reversible (cell recovers and returns to normal) or irreversible (cell death).

Cells require substrates (glucose, glycogen, lipids, proteins) for energy and function. Homeostasis represents equilibrium, but physiological demands fluctuate, compromising homeostasis and creating cellular stress. Stress can be physiological (exercise, pregnancy) or pathological (systemic hypertension affecting cardiac myocytes). Cells adapt through four mechanisms: (1) Hypertrophy - increase in cell size (e.g., cardiac hypertrophy in hypertension); (2) Hyperplasia - increase in cell number (e.g., uterine hyperplasia during pregnancy); (3) Atrophy - decrease in size and number of cells (e.g., muscle atrophy after nerve injury); (4) Metaplasia - change from one specialized cell type to another (e.g., squamous metaplasia in smokers' respiratory epithelium).

Cellular trafficking involves coordinated vesicle formation, transport, and fusion. Clathrin-mediated pathways use triskelion structures to form cages around vesicles, with dynamin facilitating pinching off. After uncoating via ATP-dependent processes, vesicles fuse with endosomes where proton pumps create acidic environments for ligand-receptor separation. Receptors recycle while ligands progress to lysosomes for degradation. Exocytosis complements this by releasing synthesized proteins, hormones, and neurotransmitters. Two pathways exist: constitutive secretion releases immediately, while regulated secretion stores vesicles until signaled. Vesicle fusion relies on v-SNARE/t-SNARE complexes and GTPases, enabling either transient openings for recycling or complete membrane integration. This bidirectional trafficking maintains cell size and membrane composition through coupled endocytic and exocytic cycles.

Vesicle trafficking relies on SNARE proteins for precise targeting: v-SNAREs on vesicles match with t-SNAREs on target membranes. This molecular recognition ensures selective fusion between compatible membranes. The mechanism explains how vesicles find their correct destinations despite the crowded cellular environment. This system is fundamental to all intracellular transport processes, demonstrating the precision of cellular logistics.

Vesicles form through clathrin-mediated endocytosis where clathrin baskets shape the membrane into spheres. Adapter proteins anchor clathrin, and dynamin constricts the neck to pinch off vesicles using GTP energy. Vesicle fusion requires SNARE proteins: V-SNAREs on vesicles bind T-SNAREs on target membranes, causing membrane merger. Rab proteins bind tethering proteins to position vesicles correctly. This machinery enables precise intracellular trafficking, with different SNARE combinations directing vesicles to specific destinations.

Transport vesicles form through a regulated process involving cargo selection (where cargo receptors bind to specific signal sequences and adapter proteins filter cargo), coat formation (where coat proteins sculpt membrane curvature), and dynamin-mediated budding (where GTPases pinch off the vesicle); vesicles then fuse with target membranes through a highly specific process involving RAB GTPases for targeting, tethering proteins for initial contact, and V-SNARE/T-SNARE protein pairs for final membrane fusion, ensuring accurate intracellular trafficking.

Cellular vesicle trafficking involves three sequential stages: budding, transport, and targeting/fusion. Budding requires coat proteins (clathrin, COPI, COPII) that induce membrane curvature and select cargo through adaptor proteins and GTPase recruitment. After release, vesicles lose their coats and associate with motor proteins using the cytoskeleton for directed transport. Targeting occurs via specific recognition: Rab GTPases on vesicles bind Rab effectors on target membranes, while complementary V-SNARE and T-SNARE proteins mediate membrane fusion. This precise trafficking system ensures accurate delivery of cellular components to their designated destinations.

The ubiquitin-proteasome system (UPS) is a cellular mechanism where E1, E2, and E3 ligases collaborate to tag proteins with polyubiquitin chains, marking them for degradation by the proteasome; this natural process has been harnessed through proteolysis targeting chimeras (PROTACs), which bring together target proteins and E3 ligases to enable selective degradation of undruggable proteins like BRD4 and CDK9, offering new therapeutic strategies for previously inaccessible targets.

A set of micro-machines recognizes disabled proteins and places a molecular tag called ubiquitin on them. This tag serves as a signal that directs the proteasome to degrade the tagged protein. Healthy proteins are rarely consumed because they lack this destruction signal, ensuring selective protein turnover.

Proteins are degraded by the proteasome, a large multi-protein complex that shreds proteins into 2-3 amino acid fragments. Only proteins tagged with ubiquitin can enter the proteasome - the ubiquitin tag serves as a molecular signal for destruction. The ubiquitin-proteasome pathway is the primary mechanism for regulated protein degradation in cells. Proteins targeted for destruction are ubiquitinated (tagged with ubiquitin molecules). The ubiquitin tag acts as a molecular signal that directs the proteasome to shred the protein. Once ubiquitinated, protein degradation is irreversible - the ubiquitin tag commits the protein to destruction. This provides precise control over protein levels in the cell.

The ubiquitin-proteasome system uses a three-enzyme cascade (E1, E2, E3) to mark proteins for degradation. E1 activates ubiquitin using ATP, E2 conjugates it to lysine residues via isopeptide bonds, and E3 ligases attach multiple ubiquitin molecules. Four or more ubiquitins form a polyubiquitin chain that signals the proteasome. The proteasome unfolds the protein, removes ubiquitin, and cleaves it into fragments. These fragments are further broken down by cytosolic proteases into amino acids for recycling.

Ubiquitination is a post-translational modification where a small protein called ubiquitin (approximately 76 amino acids) is attached to target proteins through isopeptide bonds; this process serves as a cellular quality control mechanism where misfolded or damaged proteins are marked for degradation by the proteasome. The degradation signal is determined by the type and linkage of ubiquitin chains: monoubiquitination (single ubiquitin) and multiubiquitination (multiple ubiquitins on different lysines) do not trigger degradation, while polyubiquitination (multiple ubiquitins linked together) does, with lysine 48 linkage specifically signaling degradation. The ubiquitin-proteasome system involves three enzymes: E1 (activates ubiquitin using ATP), E2 (transfers ubiquitin), and E3 (ligase that recognizes target proteins and facilitates ubiquitination). The proteasome complex (26S) consists of a 20S barrel-shaped core containing proteolytic subunits and a 19S regulatory cap that recognizes ubiquitinated proteins, unfolds them, removes ubiquitin, and feeds the protein into the 20S for degradation. This pathway is often referred to as the 'kiss of death' because attaching ubiquitin to a protein essentially marks it for cellular destruction.